Palo Alto Investors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5.32M | Hold |
|
|||||
|
2022
Q2 | $8.05M | Hold |
|
|||||
|
2022
Q1 | $9.04M | Buy |
|
|||||
|
2021
Q4 | $10.8M | Sell |
|
|||||
|
2021
Q3 | $20M | Hold |
|
|||||
|
2021
Q2 | $26M | Hold |
|
|||||
|
2021
Q1 | $31.5M | Buy |
|
|||||
|
2020
Q4 | $21.5M | Hold |
|
|||||
|
2020
Q3 | $26.1M | Buy |
|
|||||
|
2020
Q2 | $29.4M | Sell |
|
|||||
|
2020
Q1 | $29.5M | Sell |
|
|||||
|
2019
Q4 | $52.7M | Buy |
|
|||||
|
2019
Q3 | $18.6M | Sell |
|
|||||
|
2019
Q2 | $76.5M | Sell |
|
|||||
|
2019
Q1 | $130M | Hold |
|
|||||
|
2018
Q4 | $94.1M | Buy |
|
|||||
|
2018
Q3 | $153M | Buy |
|
|||||
|
2018
Q2 | $226M | Buy |
|
|||||
|
2018
Q1 | $209M | Buy |
|
|||||
|
2017
Q4 | $231M | Buy |
|
|||||
|
2017
Q3 | $274M | Hold |
|
|||||
|
2017
Q2 | $312M | Sell |
|
|||||
|
2017
Q1 | $248M | Buy |
|
|||||
|
2016
Q4 | $169M | Hold |
|
|||||
|
2016
Q3 | $137M | Hold |
|
|||||
|
2016
Q2 | $52.2M | Buy |
|
|||||
|
2016
Q1 | $66.5M | Sell |
|
|||||
|
2015
Q4 | $124M | Buy |
|
|||||
|
2015
Q3 | $286M | Buy |
|
|||||
|
2015
Q2 | $211M | Buy |
|
|||||
|
2015
Q1 | $158M | Buy |
|
|||||
|
2014
Q4 | $118M | Buy |
|
|||||
|
2014
Q3 | $78.1M | Buy |
|
|||||
|
2014
Q2 | $37.9M | Buy |
|
|||||
|
2014
Q1 | $12.9M | Hold |
|
|||||
|
2013
Q4 | $11.3M | Buy |
|